Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Dose-Response Relationship: Selectivity and Specificity01:25

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Bisphosphine ligand conformer selection to enhance descriptor database representation: improving statistical modelling outcomes.

Chemical science·2025
Same author

Stereoselective Synthesis of <i>trans</i>-3-Amino-2,2,4,4-tetramethylcyclobutanol.

Organic letters·2025
Same author

Data Science-Guided Development of Deoxyfluorination Reagents with Enhanced Reactivity, Practicality, and Safety.

Journal of the American Chemical Society·2025
Same author

Scaling Organic Electrosynthesis: The Crucial Interplay between Mechanism and Mass Transport.

ACS central science·2025
Same author

Utopia Point Bayesian Optimization Finds Condition-Dependent Selectivity for <i>N</i>-Methyl Pyrazole Condensation.

Journal of the American Chemical Society·2024
Same author

Umpolung Flow Chemistry for the Synthesis of a 3-Oxo-3<i>H</i>-spiro[benzofuran-2,4'-piperidine] Building Block.

The Journal of organic chemistry·2024

Related Experiment Video

Updated: Jul 8, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Leveraging Bayesian Optimization for Accelerated Ligand Selection in Atroposelective Negishi Coupling.

Yujing Zhou1, Richard C Walroth1, Lin Deng1

  • 1Department of Synthetic Molecule Process Chemistry, Genentech, Inc., South San Francisco, California 94080, United States.

Organic Letters
|July 7, 2026
PubMed
Summary

We developed a new Bayesian optimization strategy using chemical descriptors to speed up ligand selection for asymmetric catalysis. This method efficiently optimized a key step in making a KRAS G12C inhibitor.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Experiment Videos

Last Updated: Jul 8, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Area of Science:

  • Catalysis
  • Organic Chemistry
  • Computational Chemistry

Background:

  • Ligand selection is crucial for asymmetric catalysis but challenging under sparse-data conditions.
  • Traditional methods like multivariate linear regression struggle with complex catalytic landscapes.
  • Accelerating the discovery of efficient ligands is vital for synthesizing complex molecules.

Purpose of the Study:

  • To develop and demonstrate a descriptor-informed Bayesian optimization strategy for accelerating ligand selection in asymmetric catalysis.
  • To optimize yield and diastereoselectivity in a Negishi cross-coupling reaction for KRAS G12C inhibitor synthesis.
  • To explore the utility of DFT-derived descriptors in guiding catalytic optimization.

Main Methods:

  • Implemented a Bayesian optimization strategy informed by chemical descriptors.
  • Utilized forward-step descriptor selection integrated with Density Functional Theory (DFT)-derived descriptors.
  • Applied the strategy to an atroposelective Negishi cross-coupling reaction.

Main Results:

  • The descriptor-informed Bayesian optimization successfully optimized yield and diastereoselectivity, outperforming multivariate linear regression.
  • Identified underexploited reactivity of Phanephos ligands.
  • Achieved 84% yield and 91:9 diastereomeric ratio (dr) for the target atropisomer.

Conclusions:

  • Descriptor-informed Bayesian optimization is an effective strategy for accelerating ligand discovery in asymmetric catalysis.
  • DFT-derived descriptors can efficiently guide optimization of complex catalytic reactions.
  • The developed method enabled the synthesis of a KRAS G12C inhibitor precursor with high yield and selectivity.